Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAC: Artesunate Resistance in Falciparum Malaria
NCT01350856Phase 4Completed
- Sponsor
- University of Oxford
- Start
- May 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 10
01
Overview
Phase 4, randomised, open-label trial of artesunate in Malaria (2 arms), sponsored by University of Oxford. Primary endpoint: Parasite clearance rate at Day 42. Started May 2011; status: completed.
02
Drugs
artesunate
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT01350856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01350856.